Next-Generation Approaches for Relapsed/Refractory Multiple Myeloma: A Focus on Novel Therapeutic Targets and Pathways

Next-Generation Approaches for Relapsed/Refractory Multiple Myeloma: A Focus on Novel Therapeutic Targets and Pathways

Join us for this live symposium in conjunction with EHA 2025 in which an expert panel will discuss targeting protein degradation pathways for treating patients with relapsedrefractory multiple myeloma Sign up now

  • Provider:Clinical Care Options
  • Activity Link: https://clinicaloptions.com/events/novel-treatments-for-mm/novel-treatments-for-mm/15692-21845
  • Start Date: 2025-06-12 05:00:00
  • End Date: 2025-06-12 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
  • Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 177300.0 - Is Kind Support: False
  • Activity Type: Live Course
  • CME Finder Type: Conference
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.